Division of Cardiovascular Medicine, Department of Internal Medicine, Francois M. Abboud Cardiovascular Research Center, Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine , Iowa City, Iowa.
Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H314-H325. doi: 10.1152/ajpheart.00580.2018. Epub 2018 Nov 21.
The Mediator coactivator complex directs gene-specific expression by binding distal enhancer-bound transcription factors through its Med1 subunit while bridging to RNA polymerase II (Pol II) at gene promoters. In addition, Mediator scaffolds epigenetic modifying enzymes that determine local DNA accessibility. Previously, we found that deletion of Med1 in cardiomyocytes deregulates more than 5,000 genes and promotes acute heart failure. Therefore, we hypothesized that Med1 deficiency disrupts enhancer-promoter coupling. Using chromatin immunoprecipitation-coupled deep sequencing (ChIP-seq; n = 3/ChIP assay), we found that the Pol II pausing index is increased in Med1 knockout versus floxed control mouse hearts primarily due to a decrease in Pol II occupancy at the majority of transcriptional start sites without a corresponding increase in elongating species. Parallel ChIP-seq assays reveal that Med1-dependent gene expression correlates strongly with histone H3 K27 acetylation, which is indicative of open and active chromatin at transcriptional start sites, whereas H3 K27 trimethylated levels, representing condensed and repressed DNA, are broadly increased and inversely correlate with absolute expression levels. Furthermore, Med1 deletion leads to dynamic changes in acetyl-K27 associated superenhancer regions and their enriched transcription factor-binding motifs that are consistent with altered gene expression. Our findings suggest that Med1 is important in establishing enhancer-promoter coupling in the heart and supports the proposed role of Mediator in establishing preinitiation complex formation. We also found that Med1 determines chromatin accessibility within genes and enhancer regions and propose that the composition of transcription factors associated with superenhancer changes to direct gene-specific expression. NEW & NOTEWORTHY Based on our previous findings that transcriptional homeostasis and cardiac function are disturbed by cardiomyocyte deletion of the Mediator coactivator Med1 subunit, we investigated potential underlying changes in RNA polymerase II localization and global chromatin accessibility. Using chromatin immunoprecipitation sequencing, we found that disrupted transcription arises from a deficit in RNA polymerase II recruitment to gene promoters. Furthermore, active versus repressive chromatin marks are redistributed within gene loci and at enhancer regions correlated with gene expression changes.
中介体共激活复合物通过其 Med1 亚基与远端增强子结合的转录因子结合,指导基因特异性表达,同时在基因启动子处桥接到 RNA 聚合酶 II(Pol II)。此外,中介体支架上的表观遗传修饰酶决定了局部 DNA 的可及性。以前,我们发现心肌细胞中 Med1 的缺失会使超过 5000 个基因失活,并促进急性心力衰竭。因此,我们假设 Med1 缺乏会破坏增强子-启动子的偶联。使用染色质免疫沉淀结合深度测序(ChIP-seq;n = 3/ChIP 分析),我们发现与 floxed 对照小鼠心脏相比,Med1 敲除小鼠心脏中的 Pol II 暂停指数增加,主要是由于 Pol II 占据大多数转录起始位点的减少,而延伸种的比例没有相应增加。平行的 ChIP-seq 分析表明,依赖 Med1 的基因表达与组蛋白 H3 K27 乙酰化密切相关,这表明转录起始位点的染色质呈开放和活跃状态,而 H3 K27 三甲基化水平代表凝聚和抑制的 DNA,广泛增加,并与绝对表达水平呈反比。此外,Med1 的缺失导致与基因表达改变一致的乙酰化-K27 相关超级增强子区域及其富含转录因子结合基序的动态变化。我们的研究结果表明,Med1 在心脏中建立增强子-启动子偶联很重要,并支持中介体在建立起始复合物形成中的作用。我们还发现 Med1 决定基因和增强子区域内的染色质可及性,并提出与超级增强子变化相关的转录因子的组成,以指导基因特异性表达。新发现和值得注意的是,基于我们之前的研究发现,中介体共激活复合物的 Mediator 亚基 Med1 的心肌细胞缺失会扰乱转录本的动态平衡和心脏功能,我们研究了 RNA 聚合酶 II 定位和全局染色质可及性的潜在变化。使用染色质免疫沉淀测序,我们发现转录的中断是由于 RNA 聚合酶 II 募集到基因启动子的缺陷所致。此外,基因座内和增强子区域内的活性和抑制性染色质标记重新分布与基因表达变化相关。